{"abstract": "Amgen and Celgene are separately acquiring two smaller companies that are harnessing novel technologies to develop drug treatments for leukemias and lymphomas.", "web_url": "https://dealbook.nytimes.com/2012/01/26/biotech-companies-bolster-pipelines-through-deals/", "snippet": "Amgen and Celgene are separately acquiring two smaller companies that are harnessing novel technologies to develop drug treatments for leukemias and lymphomas.", "lead_paragraph": "Two big biotechnology companies announced on Thursday that they would buy smaller companies that are harnessing novel technologies to develop drug treatments for leukemias and lymphomas. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "2 Biotech Firms Bolster Their Drug Pipelines Through Deals", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Biotechnology", "rank": 2, "major": "N"}, {"name": "subject", "value": "Clinical Trials", "rank": 3, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 4, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Celgene Corporation", "rank": 6, "major": "N"}], "pub_date": "2012-01-26T16:04:26+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/429d700c-209c-53ff-a8df-2435d96ade48", "word_count": 634, "uri": "nyt://article/429d700c-209c-53ff-a8df-2435d96ade48"}